Do you have a solid tumor that has progressed on other treatments? Do you have at least one measurable tumor? If so, you may be able to take part in a study to improve treatment for advanced solid tumors. We are exploring how safe and effective a combination of drugs is.

In this study, researchers want to find out the highest safe dose of a drug called [212Pb]VMT-α-NET that can be used to treat neuroendocrine tumors.

Do you have a history of breast cancer? Are you done with active breast cancer treatment? Do you live in North Carolina? You may be able to participate in a research study that seeks to understand how different factors have impacted people's emotional well-being during the breast cancer survivorship period. Compensation provided

Have you been diagnosed with Severe Aplastic Anemia (SAA), but don't have a matched sibling donor? If so, you may be able to take part in a study to see if a bone marrow transplant from a donor that is not related can help treat your disease. Compensation provided.

Have you been diagnosed with cancer? If so, you may have the opportunity to participate in a research study designed to examine how central oncology navigation affects the use of supportive care services. Additionally, the study will assess whether enrollment in non-treatment clinical trials increases with the implementation of an Oncology Navigation Resource (ORN) intervention.

This study looks at why there is a large gap in academic achievement between Black and white students in public school districts located in college towns. To find answers, researchers will conduct detailed interviews with current and former teachers, school leaders, parents, and former students in the district of study. Through analysis of these interviews, the study aims to understand what factors from the past and present maintain racial inequality in the school district of study. The findings will help shed light on the causes of racial differences in educational outcomes and suggest ways to make education more equitable in public school districts located in college towns.

In this study, we want to see how well a new drug called Quizartinib works for people with Leukemia who do not have a specific mutation called FLT3-ITD. We want to see if this new drug helps improve the condition.

This study is researching the treatment outcomes and long-term effects of a drug called Dupixent in treatment of patients with Eosinophilic Esophagitis (EoE).

The purpose of this study is to find out how safe and effective a new CAR-T study treatment, called MB-105, is for people with T-cell lymphoma. MB-105 is an experimental study treatment. This means it is not approved for general use by the U.S. Food and Drug Administration (FDA) and, as such, can only be used in research studies.

In this study, we are trying to understand how students feel when they look for help after going through sexual misconduct or violence. We also want to find ways to support those who have been affected.